Showing results (1-10 of 33) with videos related to
Sort By:
Pageof 4
The International Journal of Biological Markers|January 1, 1993
Chronic effects of subcutaneous interleukin-2 therapy on soluble interleukin-2 receptors in advanced small cell lung cancerS Viviani, P M Salvini, P Bidoli, et al.Respiration; International Review of Thoracic Diseases|April 25, 2000
Malignant mesothelioma in subjects with Marfan's syndrome and Ehlers-Danlos syndrome: only an apparent association?M Bisconti, A Bisetti, P BidoliTumori|December 31, 1985
Antiemetic activity of metoclopramide versus alizapride during cancer chemotherapyM Zambetti, E Bajetta, P Bidoli, et al.Ecancermedicalscience|July 20, 2016
Targeted therapies and immunotherapy in non-small-cell lung cancerD Cortinovis, M Abbate, P Bidoli, et al.Journal of Pineal Research|April 1, 1992
Normalization of the light/dark rhythm of melatonin after prolonged subcutaneous administration of interleukin-2 in advanced small cell lung cancer patientsS Viviani, P Bidoli, S Spinazzé, et al.Minerva Chirurgica|February 20, 2003
[New strategies in the treatment of esophageal cancer]P Bidoli, S Aglione, L Toffolatti, et al.Anticancer Research|March 1, 1997
Comparative in vitro sensitivity of human cholangiocarcinoma and colon adenocarcinoma cells to anticancer agentsR Villa, D Gornati, N Zaffaroni, et al.La Radiologia Medica|March 1, 1989
[Radiologic examination in assessing the response to chemoradiotherapy of esophageal spinocellular carcinoma]G Cozzi, A Pestalozza, M Bellomi, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2006
Small cell lung cancerG Rosti, G Bevilacqua, P Bidoli, et al.American Journal of Clinical Oncology|October 1, 1990
Pilot study with cisplatin, ifosfamide, and etoposide in advanced non-small-cell lung carcinomaP Bidoli, S Spinazzè, A Santoro, et al.Pageof 4